Crossmark

A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice

Crossref DOI link: https://doi.org/10.1186/s13024-015-0033-8

Published Online: 2015-09-03

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Neumann, Ulf

Rueeger, Heinrich

Machauer, Rainer

Veenstra, Siem Jacob

Lueoend, Rainer M.

Tintelnot-Blomley, Marina

Laue, Grit

Beltz, Karen

Vogg, Barbara

Schmid, Peter

Frieauff, Wilfried

Shimshek, Derya R.

Staufenbiel, Matthias

Jacobson, Laura H.